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Abstract
DENTAL VISUAL SUPPORT SCHEDULE APP FOR BEHAVIOR MANAGEMENT
OF PEDIATRIC DENTAL PATIENTS WITH AUTISM: PILOT STUDY

DEGREE DATE: September, 2020
ANA L. GONZALEZ CACERES, D.D.S.
NOVA SOUTHEASTERN UNIVERSITY COLLEGE OF DENTAL MEDICINE

Directed by: Romer Ocanto, D.D.S., M.S., M.Ed. (Committee Chair)

Background: Autism Spectrum Disorder (ASD) is a prevalent neurodevelopmental
disorder in the U.S (about 1 in 54 children). Treating children with ASD in the dental
office can be challenging due to their impairments in social interactions, communication
and aversive behavior. Visual Support Schedules are visual aids or picture cues that have
been beneficial for the behavior management of patients with ASD. There are limited
studies regarding effective behavior management techniques that could help those patients
have a better experience at the dentist. Methods: A Visual Support Schedule App was used
for behavior management compared to Tell Show DO (TSD) on a randomized clinical trial
study with a sample of 8 participants with ASD during a routine dental visit at Mailman
Segal Center dental clinic. Data was collected regarding the number of tasks the patient was
able to complete and the time required for their completion. The level of stress that patients
experience during the dental visit was measured using biological markers (Heart Rate and
Salivary Cortisol). Also, the perception of the patient’s behavior by parents was measured
using a Likert Scale, as well as using the Frankl scale. Objective: Determine the efficacy of
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a Dental Visual Support Schedule App to help children with ASD successfully complete a
routine dental care visit. Results: Research was interrupted due to COVID- 19. Only 8 out
of 15 participants were enrolled. All participants were male. No significant difference was
found in age, gender, and ethnicity between intervention and control groups. There was not
statistical significance for the number of tasks completed. Conclusion: Overall, significant
differences were not found between the groups. The deficient data collected limits the
possibility of drawing strong conclusions that the App can facilitate a routine dental visit
for patients with ASD. More research is suggested.
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CHAPTER 1: INTRODUCTION
1.1 Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized
by persistent deficits in social interactions, communication, and by restricted, repetitive
patterns of behavior.1 It is considered a “spectrum” because people diagnosed with it can
have a variying degree of impairement that can range from mild to severe.2
Epidemiological surveys of Autism conducted in several countries have estimated a
global median prevalence of the condition of approximately 1 in 588. 3,4 In the United
States, there has been an increase in the prevalence of children identified with ASD, from
1 in 59 to about 1 in 54.5 Systematic reviews of epidemiologic studies suggest that
changes in case definition and increased awareness account for much of the apparent
increase.6
According to CDC’s Autism and Developmental Disabilities Monitoring
(ADDM) Network, the median age for first diagnosis is by four years of age. ASD occurs
in all racial, ethnic, and socioeconomic groups. Recently, it was found that there is no
difference in the number of black children identified with autism compared to white
children. However, the number of Hispanic children identified with autism is still lower
compared to white or black children.5 It is about four times more common to occur in
boys than in girls.1, 5
1.1.1 Comorbidities
Frequent comorbidities in individuals with ASD include epilepsy, gastrointestinal
disorders, sleep disorders, feeding/eating issues as well as other mental problems as
ADHD, depression, and anxiety.7,8 A study conducted by Van Steensel et. al (2017)
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identified anxiety disorders as the most prevalent comorbidities (about 40%) in youth
with ASD. The study also identified that children and adolescents with ASD have higher
anxiety levels compared to typically developing children.9
1.1.2 Etiology
ASD is a heterogenous neurodevelopmental disorder with unknown exact cause,
however research suggests that there might be a genetic component as well as the
environment can affect development leading to ASD.10 Some implicated risk factors for
ASD include: older parents, having siblings with ASD, low birth weight, intrauterine
infections, metabolic disorders, intrauterine exposures to some teratogenic drugs, and
premature birth. Children with certain genetic conditions such as Down syndrome, fragile
X syndrome, seizure disorder, phenylketonuria, and Rett syndrome are shown to have
ASD more often than other children with no genetic conditions.11,12
1.1.3 Diagnosis
The American Academy of Pediatrics recommends screening for developmental
delays at 9, 18, 24 or 30-months, and specifically for ASD at their 18 and 24 months well
visits. The diagnosis of ASD is made by a collaboration of professionals including
neurologists, psychologists, psychiatrists, and speech pathologists. Early signs of ASD
may include: lack of babbling or pointing by age one, no single words by 16 months or
two-word phrases by age two, unresponsiveness to name, lack of language or social
skills, poor or no eye contact, repetitive behavior of lining up of toys or objects, and/ or
lack of smiling or social responsiveness.2,13 Earlier diagnosis of ASD is crucial,
preferably in the first two years of life, as early intervention provides the best opportunity
to support healthy development and deliver benefits throughout life. Evidence suggests
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that early treatment can maximize long term prognosis; treatment results decline when
diagnosis is made later in life.14
Up to this date, the diagnosis of ASD is still mainly based on clinical
observation.15 Advances in Neuroscience are expected in the fields of biomarkers as well
as neuroimaging. ASD, as many other neuropsychiatric disorders, has evolved over time,
secondary to the progress of scientific knowledge at its time. Nowadays, the most used
diagnostic criteria are then ones stated in DSM5 and CIE11 from the World Health
Organization: WHO, based upon the simultaneous presence of all three of the triad of
severe impairment of reciprocal social interaction, severe impairment of reciprocal
communication, and severe restriction of imagination and behavioral repertoire.16,17
(Appedix A)
1.1.4 Treatment
Only a few decades ago, autism was considered a rare childhood disorder.18,19 The
progressive and substantial increase in the number and detection of children with ASD
has led to increased visibility, social awareness and demand for care services. This fact
has fostered growing interest in issues such as the most convenient and effective
screening, diagnosis and treatment procedures.
Understanding and theoretically deepening in the knowledge of autism,
developmental disorders and, in general, evolutionary neuropsychiatric disorders known
as autism spectrum disorders, is a scientific challenge of remarkable significance.
Since Kanner first described autism in 1943,20 multidisciplinary teams have been
applying and adapting the therapeutic means valid for these disorders in each time period
as the concept of the disorder evolved. In the search for a definitive treatment, which is

3

yet to come, a wide range of therapeutic options have been tested, including those that
come forth from the domain of modern Western medicine.
The lack of such definitive curative treatment has generated a growing and
enthusiastic widespread interest in advancing and discovering effective methods of
intervention. In quite a few occasions, this has brought about disorientation and false
expectations. In addition, a maelstrom of information and its problems, arising from the
growing impact that the media and the new information technologies produce, even more,
in this field.
Increasingly, the problem of uncontrolled dissemination of untested or
scientifically proven therapeutic intervention proposals, based on testimonial or anecdotal
information, but with an intense emotionally persuasive component, is being exacerbated.
Therefore, current intervention models need to have proven evidence of their
effectiveness through the use of methodologically rigorous research designs.21,22
Although there is sufficient evidence that the earlier therapeutic intervention in
the lives of these children begins, the better results will be obtained,23 the correct choice
of appropriate treatment for autism spectrum disorders is a deeply complex, controversial
topic that casts doubt in both families and professionals interested in providing high
quality early intervention.
Despite the uncertainty and conflict it generates, regarding the therapeutics of
these disorders, it has been confirmed that it is possible, through the application of
specific therapies and developing supporting resources, to improve the quality of life of
these patients and their families. Unfortunately, this is only feasible for those in
geographical areas with appropriate accessible clinical, educational, and social services.
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The concepts of evidence-based interventions were originated in the field of
medicine in the late 1960s, early 1970s, and gradually many other disciplines have
incorporated them in recent years.24
Due to the heterogeneity of the population and the limited number of research
projects carried out, the American Psychological Association developed in 2006 a
broader concept (evidence-based practice in psychology) that is better suited to
interventions with people with ASD.
Evidence-based practice is defined as the integration of the best and most up-todate evidence in scientific research with clinical-educational expertise taking into account
the perspectives of relevant stakeholders, with the aim of facilitating decisions for
evaluation and intervention that are considered effective and efficient for a particular
person.25
The term of evidence-based practice is broader than that of evidence-based
treatment, since it is not only limited to clinical practice, but also takes into account the
needs, values, cultural scope, and individual preferences of patients and their integration
into decision-making on the care of the individual. 26
The term intervention is quite often used in Psychology and Education. It is
introduced into Psychology through clinical-therapeutic application, following in a
certain way the medical therapeutic model, and then it is transferred to the proper
educational field.27
With the main goal of evaluating the effectiveness and/or efficacy of psychoeducational interventions for the improvement of any of the symptoms of the ASD,
international institutions and organizations have subsidized research through systematic
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reviews to verify, investigate and identify the most effective intervention models in
people with ASD.
These reviews allowed the publication of different clinical guidelines, which
represent an important advance in the organization of the knowledge regarding the
different types of treatment for ASD.
Treatment modalities. The range of treatments available for autism is extensive and
classified in several diferent ways. Mesibov et all classified interventions into three main
groups: Psychodynamic, Biological, and Educational and Behavioral. In the resent review
by Medavarapu et al, after reviewing 130 articles searching for the evidence of the
efficacy of each traeatmet for ASD. They organized the treatment modalities based on the
evidence of proven and unproven benefits. 28 As shown in Figure 1.
Treatment goals. Patients on the ASD require a comprehensive and multidisciplinary
treatment approach that must be individualized and developmentally appropriate.
Intensive behavioral and educational interventions are primary components of treatment
programs for ASD. These interventions are more effective when initiated as early as
possible. The goals of treatment are to maximize functionning, move the child towards
independence by facilitating learning and acquisition of adaptive skills; and to improve
the quality of life of individuals with ASD. 29,30
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Figure 1: Treatment modalities with proven and unproven benefits. Source: 28
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1.1.5 Behavioral Therapies
1.1.5.1 Applied Behavior Analysis
Applied Behavior Analysis (ABA) is a type of behavioral intervention that is
focused on the improvement of socially significant behaviors to a meaninful degree.31
This evidence-based approach, has been used successfully to treat aberrant behaviors in
people with developmental disabilities and mental conditions32 and to help caregivers,
parents, and educators teach daily life skills to children with ASD. 31 It can be applied in
different settings and to different populations as suggested by Woods et al. 33 Basic
principles of ABA are based on research done by B. F. Skinner called Operant
Conditioning. Skinner demonstrated that behavior response can be developed or changed
over time by providing reinforcing consequences for the target behavior response referred
to a behavior shaping.34 ABA treatment may target the development of new skills, and/or
minimize behavior that can interfere with a child’s progress.
The core symptoms of ASD including impairement in communication and
aversive behavior represents a challenge for dental professionals. In children with ASD,
speech delay or inability to use verbal language often plays a central role in the outcome
of successful dental treatment. Compromised communication can lead to an inability to
express discomfort or pain related to dental treatment causing significant aggressive
behavior in these children.
Dentists may need to learn alternatives and adjunctive behavior management
techniques not currently addressed in most dental training curricula to successfully
manage patients with ASD and to provide effective and complete oral health care to meet
their needs. Romer et al has recommended and implemented an interdisciplinary and
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collaborative program to train general and pediatric dentist to individualise the dental
experience of patients with ASD by implementing behavior management strategies based
on ABA including positive reinforcement, sistemic desensitization and visual support. 35
The use of these procedures in dentistry has the potential to increase the acceptance of
routine dental preventative procedures by patients with ASD.31
1.2 Autism Spectrum Disorder and Oral Health
The oral health of individuals with ASD presents some particular characteristics.
Although, there does not seem to be any oral manifestations specific to autism, certain
conditions may appear due to behaviors related to autism, such as communication
limitations, personal negligence, self-injurious behavior, eating habits, effects of
medications, resistance to oral care, and hyposensitivity to pain. 36 A study conducted by
Loo et. al (2008) revealed a remarkable increase in caries among children with ASD as
compared to neurotypical children.37 Major etiological factors contributing to higher
incidence can be uncooperative behavior, eating habits, and poor oral hygiene.
Furthermore, irregular eating habits with sweet snacks and longer duration of oral
clearance can lead to dental decay in these patients.38 Recent studies have found that in
spite all the risk factors that these children are exposed to, the caries index are not higher
when compared to neurotypical individuals.36 For these reasons, children with ASD
should have ready access to preventive dental care, needed dental treatment, and ongoing
monitoring of their oral health by stablisihng a dental home by age 1 as recommended by
the AAPD.
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1.2.1 Dental Home
Dental home is the ongoing relationship between the patient and the dentist in a
familiar and safe health supervision.39 It was defined by the Council on Clinical Affears
of the AAPD and adopted in 2006 following the medical home concept.
For patients with Autism it is crucial to stablish a dental home to provide anticipatory
guidance regarding diet, oral hygiene , trauma prevention and preventive services as
routine dental prophylaxis to prevent oral diseases.
1.2.2 Barriers to Dental Care in Children with Special Health Care Needs
Dental care is identified as the most prevalent unmet health care need for
approximaely 10.2 million children in US with special health care needs.40 Low income
and minority children with special health care needs are recognized to be at greatest risk
due to poor oral health and deficient access to care.40 The prevalence of unmet dental
need in children with ASD is 12-15% compared to typical children which is
approximately 5%.41 A recent study done by Wirth and Gabor (2016) identified reasons
for this disparity: imbalance between number of medical providers that are providing
services to children’s with ASD and need for available medical provider. 42 Similiarly,
Spangler (2016) reported increasing demand for dentists who work with special needs
patients.43 Children with ASD have behaviors and sensitivities that make dental treatment
one of the most difficult types of health care to receive. Lai et al. (2012) found that
behavior of children with ASD was the prominent barrier to dental treatment,
contributing to their unmet dental needs.44 The percentage of patients with ASD that
require treatment under general anesthesia due to lack of cooperation varies between 37%
and 76%, increasing the expenditures for dental treatment.45 Presence of cognitive
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dysfunction, aggression, convulsions, and other associated symptoms can minimize inoffice dental treatment of these patients.45 Other problems that may be exhibited by
patients with ASD include the inability to manage emotions, repetitive body movements,
hyperactivity associated with attention deficiency, and low frustration threshold which
can generate peevishness and atypical vocalizations.12 Several studies have identified
factors that are associated with difficulty in dental care; these include speech delay,
developmental delay and inability to perform daily self-care activities.46,47,48 The dental
team should be prepared for changes in atypical responses to sensory stimuli, as these
patients are not easily adaptable to little changes in their environment and require
similarity in their routine.12
1.2.3 Behavior Guidance Techniques for Dental Care
It has been reported that there are unmet challenges for patients with ASD when
seeking medical and dental care due to their impairment in communication, sensory
aversions, anxiety, and difficulty with the management of new situations that can lead to
defensive behaviors.29,49 Their fear and anxiety towards dental procedures cause
reluctance in parents to take them to routine dental visits putting those patients at higher
risk for oral diseases including caries, gingival inflammation, and infection compared to
the general population. Their difficult behavior, extra time required for appointments, and
lack of proper professional training to successfully manage the aberrant behavior in the
dental visit also represents a challenge for dentists. ASD is one of the most frequent
indications for providing dental care using pharmacologic behavior management
techniques as treatment under general anesthesia or sedation. 37,50,51 Therefore,
desensitization and regular preventive dental visits are extremely important to maintain
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the oral health of those patients since early in life and to avoid more invasive, extensive,
and costly dental care under general anesthesia. 52
For children with ASD, it is difficult to understand and cooperate with medical
instructions. While neurotypical children may also have trouble being cooperative, it has
been shown that ASD patients present more challenging behaviors.37 Furthermore,
children with ASD often have heightened oral sensory perception, meaning they have
hypersensitivity to textures and may become defensive to oral input. Despite all
challenges, there is limited research addressing behavior management techniques and
procedural modifications that dentists can use to treat children with Autism. 31
Behavior guidance techniques recommended by the American Academy of
Pediatric Dentistry (AAPD) are applied universally in pediatric dentistry, including to
patients with special needs. Tell- Show-Do, distraction and positive reinforcement are
some of the techniques recommended by AAPD for behavior management. Treating
children with Autism in the dental office can be challenging due to their impairment in
social interactions, communication, and their difficulty to manage novel situations.
Additionally, core symptoms of ASD including social and communication deficits like
lack of joint attention may make commonly used behavior management techniques like
Tell-Show-Do ineffective for some patient with ASD. Dentists may need to learn
alternative and adjunctive behavior techniques not currently addressed in most dental
training curricula to successfully manage patients with ASD and provide effective and
complete oral health care.
Current behavior guidance procedures such as tell-show-do, voice control, and
positive reinforcement are effective with children. 53 However, these do not necessarily
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address the behavioral characteristics of patients with ASD, because they are often
dependent upon the ability to attend to a model and sustain joint attention.31,52 Many
strategies have been proposed to facilitate routine dental care for patients with ASD.
These include desensitization, creating a minimally stimulating environment, structured
appointments,52 and visual pedagogy a technique used to familiarize children with the
treatment tools and processes through a set of pictures. 38 Social stories (a behavioral
intervention used for children with ASD that consist of a short sequence of pictures and
sentences describing a situation),46,52 alternative and augmentative communication
systems,46 and visual supports are other methods described for behavior management in
the dental office. Unfortunately, none of these strategies are completely effective to
secure cooperation and more research is needed.
Tell Show Do. Tell Show Do is used with both the cooperative and uncooperative child
and involve a verbal explanation of procedure in a friendly and age appropriate terms
(Tell); allow the child to physically interact with aspects of the procedure as instruments
via senses (Show); and then perform the procedure (Do).53 The goal of the technique is to
familiarize the patient with the dental setting and shape the patient’s response to the
procedures. For patients with ASD this technique may be ineffective due to their lack of
join attention.
Voice Control. In Voice control procedures, the provider alters the voice volume, tone
and/or pace to influence and direct the patient’s behavior. The objective of this technique
is to gain attention and compliance from the patient as well as to stablish adequate adultchild role. This procedure might be ineffective for patients with ASD due to missing
receptive language to understand the directions given.
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Positive reinforcement. Positive reinforcement rewards desired behaviors thereby
strengthening the likelihood of recurrence of those behaviors. It includes social reinforces
as verbal praise and non-social reinforcers including toys. For patients with ASD positive
reinforcement is required immediately after the occurrence of desired behavior.
1.2.3.1 Behavior guidance strategies based on ABA for dental setting
Visual Supports/ Task Strips/Alternative and Augmentative Communication
Procedures adapted from ABA can be used for management of patients with ASD
in the dental office. Children with ASD have been characterized as visual learners. 50,54
Visual support are any visuals (pictures, photographs, objects, words) used to
support individuals with ASD to increase their understanding of what is being said and
what is expected. Alternative and augmentative communication systems (AAC) are forms
of visual support, which consist in using pictures or photographs, and is a common tool
in communicating and educating individuals with ASD. 54 These procedures based on
ABA, are used in autism not just to replace speech, but to assist learning and
communication, regardless of the level of speech. Symbols, pictures, photographs and
objects of reference, are all well established as helpful for people with autism in
supporting the comprehension of what is said and in getting needs met.55
Visual support schedules can be used to communicate schedules and routines in
either picture or written format, allowing individuals with ASD to more easily transition
between tasks.56
In the dental setting, the use of visual suports can be a beneficial resource to build
communication between the dentist and the individual with ASD. It can also allow the
individual with ASD to anticipate dental treatment ahead of time before it is rendered.57
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A study done by Cagetti et al (2015) demonstrated that use of visual supports can
facilitate dental treatment in children with ASD. Additionally, it is also effective in nonverbal children with low intellectual disability as long as visual supports are used as the
first line of behavioral approach to treat patient with ASD in dental settings.50
The task strips or visual supports (ilustrated in Fifure 3) are the gold standard at
the Nova Southeastern Univeristy Mailman Segal Center (MSC) for Development
pediaric dental clinic during desensitization. The task strip provides the visual structure
and routine of the dental visit which can help to reduce anxiety and behaviors in these
patients. The task strip provides the child with a visual representation of each step; this
visual shows the patient what they are doing and what they are expected to do next,
allowing the child to be actively engaged in the process of the dental visit. After
completion of task strip patient is rewarded with prize from the treasure box as a positive
reinforcement along with praises after completion of every step in the task strip.

Figure 2. MSC task strip visualization
Technology-based intervention for Autism Spectrum Disorder
Touch screen devices as smartphones and tablets, have been the trend in the recent
years and their accessibility and affordability have significantly increased. Developers are
15

consistently creating applications that run on these devices, and apps for individuals with
ASD are not the exception. They are a non-expensive addition to existing therapies for
patients with this condition58 and the literature have shown that there is a continuous
increase in the use of technology-based interventions for Autism.
A systematic review completed by Lorah et. al reported that in 2014 there were
about 400 iPad applications on the Autism Speaks website and the majority of those Apps
are supported only by anecdotal evidence.59 As of today a Google search of ‘‘autism and
app’’ generates over a100 million hits in (0.56 seconds) and about 36,500 results in
google scholar.
Effective technology-based programs dedicated to addressing the core symptoms
of ASD are gradually gaining recognition among researchers and practitioners and have
gone considerably beyond the use of desktop computers. This now includes the use of
robotics, handheld and touch pad devices, Internet based collaborative virtual
environments, eye tracker–based gaze-contingent visual displays, among
others. Innovative technology-based interventions address a variety of skills essentials
for individuals with ASD, including the ability to initiate, maintain, or terminate a
behavior; functional activities of daily living, and to enhance vocal imitation.60
After years of dedicated intensive research in this field, technology-based treatment
is still perceived as “emerging” rather than “stablished”, and their clinical validity is still
in debate because due to the novelty and interdisciplinary nature of the field, not all
published articles assess treatment efficacy. The evidence suggests that technology
may enhance motivation, increase attention, and reduce challenging behavior in
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individuals with ASD. According to the New Zealand Autism Spectrum Disorder
Guideline, use of visual supports and technology should be available to support the
development of both, expressive and receptive communication. 61
The use of handhelds as an assistive technology for visual supports and video
modeling for students with disabilities has many benefits over traditional low-technology
options including enhancing receptive communication, more timely delivery of
instructions, providing a clearer understanding of the task at hand, reducing instructional
wait time, and increasing time on-task.62 Apps can provide teachers with easily accessible
tools to enhance teaching and learning. Particularly, there are a multitude of apps
available that can assist with the specific learning needs of students with ASD. The use of
visual pedagogy through visual activity schedules is a common and efficient practice
in children with ASD. Furthermore, numeric devices, such as the iPad®, are
increasingly integrated in the education of children with ASD, and this device has shown
some promising results, even in the dental domain. 50
In dental care setting, there are many strong sound-visual stimulations that are
different from those in any other setting. This usually upsets a patient with
autism, often forcing dentists to administer an anesthetic in order to carry out dental
procedures. However, the positive attitude of people with autism regarding technology
has been used to simplify oral care with positive results. 15
A recent study completed using a digital iPad application with patients with
Autism shows positive results, with patients becoming more compliant and less anxious
during dental appointments.48
A wide knowledge of the positive effects of technological interventions in the life
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of people with ASD emerges from the literature, but there is little research in the specific
field of personalized digital tools to facilitate ASD dental care.15
1.3 Mailman Segal Center for Human Development
1.3.1 Baudhuin Preschool
Baudhuin preschool, located at Mailman Seagal Center is a special school that
models international recognized programs for children with ASD. This school program
utilizes principles of Applied Behavior Analysis (ABA), which focuses primarily on the
development of cognitive, social, adaptive, behavioral, motor, and communication skills
with these children.
1.3.2 Kapila Family Foundation Starting Right
Starting Right is an early intervention program for children with delay in
communication and social skills that is part of Nova Southeastern University's Mailman
Segal Center. The program, provided by behavioral specialists, is designed to increase
communication, social and school readiness skills. It also familiarizes caregivers with
strategies to use with their children in different settings.
1.3.3 Pediatric Dentistry Residency Program
The residency program in Pediatric Dentistry at Nova Southeastern University is
a two year post-doctoral program, accredited by the Commision on Dental Accrediation
(CODA). The programs is designed to train residents to successfully achieved the
knowledge and skills to provide evidence based, high quality oral health care to children
and adolecents including patients with special needs. Residents have the opportunity to
rotate through different hospitals and extra-mural afiliations including the Mailman
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Seagal Center where they can achieve proficiency in the management of patients with
ASD.
1.3.4 Health Resources & Services Administration (HRSA)
The Health Resources and Services Administration (HRSA) is a federal agency
that aims to improve health outcomes and address health disparities through access to
quality services, a skilled health workforce, and innovative, high-value programs. In
2010, HRSA funded a grant to Nova Southeastern University College of Dental Medicine
(NSU-CDM) under the Residency Training in General and Pediatric Dentistry program to
help meet the oral health needs of special needs patients, specifically those with ASD and
the training needs of pediatric dental residents. This funding allowed the creation of the
one operatory dental clinic located at MSC, which is equipped to provide comprehensive
pediatric dental care to children with ASD from infancy to late childhood.35
1.3.5 Mailman Segal Center Dental Clinic
MSC dental clinic, located in Broward county, Florida is a single chair dental
clinic that is specialized for the dental treatment of childern with ASD. All the treatment
provided by the dental clinic if fully funded by HRSA grant. The clinic has dedicated
ABA therapist on staff that provide there expertise and guidance for behavior
management during the dental treatment. Pediatric dental residents are part of a
collaborative team and learn different techniques and skills utilized by the onsite faculty
pediatric dentist, clinic staff including ABA therapist on the grant, and the Baudhuin
preschool employees.
Current Study
Considering that people with autism have preference for processing visual
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information and they are very attracted by technology, we are implementing the use of a
visual support free App (Figure 2) created by the principal investigator based on the same
principles of the existing task strips used at MSC clinic to improve dental behavior in
children with ASD. A dental visual support App was created using an interface at
Mobincube website with the objective to make an electronic and easily accessible version
of the existing task strips. Colorful and more appealing images were used. This App has
an easy to use (back and forward) design for children, caregivers, and dentists.

Figure 3. Visual Dental Schedule App
1.4 Purpose, Specific Aims and Hypotheses
1.4.1 Purpose
ABA has been shown to teach children with ASD to be compliant with medical
procedures, however research on training these children to be compliant with dental

20

procedures are limited.31 Few studies have examined the efficacy of initial dental
desensitization in relation to successful dental exams, and studies are needed to examine
the effectiveness and long-term sustainability of dental desensitization in improving the
comprehensive dental health and behavior of children with ASD. In order to reduce the
caries occurrence, facilitate tolerance, and increase the compliance toward dental
treatment, research is needed to determine the factors that can predict sustainable positive
attitudes and successful dental visits in these children.
There is limited research supporting electronic behavior management techniques
to treat patients with ASD in the dental office. There are many basic and advanced nonpharmacological behavior management techniques including Tell-Show-Do, positive
reinforcement, and physical protective stabilization53 used to improve the outcome of the
dental visit. It has been reported in recent research that using a visual support schedule
(task strips) helps patients with ASD to see and understand step-by-step what is needed to
complete a routine dental visit.50,51 Considering that people with autism have preference
for processing visual information and they are very attracted by technology,48,51 an app
was created to improve dental behavior management of patients with ASD. One of the
advantages of the App over the existing task strips is the availability to be downloaded by
all interested dental health care providers and parents to train the child about the dental
visit prior to coming to the actual dental appointment. This App is easy to use, appealing
with child friendly images and very simple (back and forward) design, interactive and
didactic for children. It also advances the dentist’s clinical behavioral interventions. A
recent study completed using a digital iPad application with patients with Autism shows
positive results, with patients becoming more compliant and less anxious during dental
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appointments.48
This research project innovation sought to identify the role of the App as
behavior management in the dental clinic by improving their compliance and tolerance
towards dental visits. The use of the app based on visual pedagogy has shown to be able
to facilitate children with ASD to undergo dental treatments even in non-verbal children
with a low intellectual level when used as the first strategy in dental setting. 50 Research
indicates that regular and gradual exposure to stimuli can improve acceptance of the
instruments and materials used in the dental office.54 This project may also serve as a
resource to inform academic organizations in dentistry and medicine (ADA, AAPD,
AAP) to implement certain guidelines regarding behavior management and health
promotion aspects in children with ASD. Thus, sustained effects of ABA may be
efficacious in improving dental outcomes for young children with ASD. This project
aims to inform dentists, specialists, and physicians of the potential of digital visual
support in building sustainable patient tolerance and acceptance towards the dental visits.
This study based on data collected at the MSC could be beneficial in developing
awareness among parents and healthcare workers regarding the benefits of ABA in
improving oral health and behavior along with reduction in cost to achieve the optimal
care. This study may be a valuable in future behavior management and health promotion
research in the dental field. Thus, this research can contribute to the solution of unmet
dental needs in children with ASD and improve the oral health in these children.
1.4.2 Specific Aims
This study considers the limited research regarding effective behavior management
techniques that could help patients with Autism during a dental visit. For the purpose of
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this crossover pilot study the use of an App was compared with the Universal Standard of
Care recommended by AAPD for behavior management of children (TSD: Tell- ShowDo). The Mailman Segal Center (MSC) current standard of care is the use of visual task
strips and TSD for patients with ASD. The use of the App was only used for patients
participating in this study.
The overall goal of this pilot clinical trial was to evaluate the efficacy of the Dental
Visual Support Schedule App to help children with ASD successfully complete a routine
dental care visit at the MSC.
My specific aims were as follows:
1: Determine if the use of the Dental Visual Support Schedule App helps
patients with ASD improve the behavior during a routine dental visit by
evaluating the number of task completed, the time needed to complete all
tasks, parental perception questionnaire, and by Frankl Behavior Rating
Scale.
2: Evaluate if using the Dental Visual Support Schedule App decreases the
distress level that patients with ASD experience during a routine dental
visit determined by physiological biomarkers: heart rate and salivary
cortisol levels.
3: Determine if the use of the Dental Visual Support Schedule App allows
patients with ASD to complete all tasks with fewer dental appointments,
indicating greater desensitization.

23

CHAPTER 2: METHODS
2.1 Study Design
This was a single center, randomized, clinical trial pilot study that involved eight
participants from Nova Southeastern University's Pediatric Dental Clinic at the MSC.
2.1.1 Institutional Review Board (IRB) Approval
IRB approval was granted on December 19, 2019 for this study. Approved IRB
number: 2019-552-NSU .
2.1.2 Ethical Issues
Since this study was conducted on human subjects, informed consent was
obtained. The following items were communicated to each participant’s authorized
surrogates:


purpose of the research, its expected duration, and the nature of any
interventions/experiments;



anticipated risks and benefits of participation and the reasonable alternatives to
participation in the research protocol;



confidentiality provisions relating to the research records;



the right to not participate and to discontinue participation at any time without
penalty.
All Protected Health Information (PHI) identifiers were removed to comply with

IRB and HIPPA regulations.
2.1.3 Grant
This research study was awarded funding by the Health Professional Division
Research Committee at Nova Southeastern University (HPD Grant No: 334586)
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2.1.4 Sample Size
The estimated sample size was 15 patients. The convenience sample was based on
eight published crossover studies conducted in dentistry, which had a mean sample size
of 25 participants (with a minimum of six and a maximum of 40 individuals.63-70 To
confirm the sample size, we employed the following formula:
n (per group) =

2 𝑥 (𝜎 2)𝑥 [Ζ𝛼⁄ +Ζ ]2
2 𝛽
∆2

:

The sample-size estimate was based on exact tests with actual levels of
significance and power. In a single-arm study with P0 (unacceptable response rate) =10%,
P1 (response rate that is desirable)=90%, specified α=5% and power=80%, the A'Hern
approach yields n=15 (exact α=0.02%, power=79.8%).
Due to the COVID-19 pandemic and associated closure of the Mailman Seagal Center
(MSC) dental clinic, the study was interrupted and as a result, we ended up with a sample
of 8 patients enrolled.
2.1.5 Sample Description
The eight patients enrolled in this study were new patients at the MSC dental
clinic located in Broward county, Florida. All patients were diagnosed with Autism by a
physician before participating in the study. The MSC clinic is a single chair dental clinic
that is specialized for the dental treatment of childern with ASD. All the treatment
provided by the dental clinic was fully funded by HRSA grant.
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2.2 Sample Population
2.2.1 Inclusion criteria and exclusion criteria
Inclusion criteria:


Patients diagnosed with Autism Spectrum Disorder.



Patients between 3 and 9 years old.



Patients from both genders (females and males) were included. Prior to
recruitment, it was anticipated that we would have a higher number of males
enrolled due to the significantly higher prevalence of Autism in males (4
males to 1 female).

Exclusion criteria:


Patients previously treated at Mailman Segal Center who were already
desensitized with a visual task strip.



Low vision patients impeding visualizing the App.



Patients (parents/caregivers) refusing consent for participating in the study.

2.2.2 Dependent variable
1. Number of tasks completed (Discrete)
2. Time to complete all tasks (Continuous)
3. Number of visits needed to complete all tasks (Discrete)
4. Parental Perception of children’s behavior improvement (Dichotomous)
5. Parental Perception of overall behavior (Ordinal)
6. Parental Perception of aggressive behavior (Dichotomous)
7. Parental Perception of cooperative behavior (Dichotomous)
8. Score obtained from Frankl Behavioral Rating Scale (Ordinal)
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9. Score obtained from modified Venham Anxiety Scale (Ordinal)
10. Heart Rate (Continuous)
11. Cortisol levels (Continuous)
2.2.3 Independent Variables
1. The patient’s demographics (age, gender, ethnicity)
2. Exposure to Visual Support App (Dichotomous)
2.2.4 Limitations
External validity was affected by the sample size and limited to children with
ASD aged 3 to 9 years old, which is the age limitation for the Mailman Segal Center. Due
to COVID 19 pandemic it was not possible to continue with the study to complete the
washout period and the crossover for the second intervention for each group.
2.2.5 Cofounders
Potential cofounding variables included participants exposure to different
resident providers for follow up visits during the research and other undiagnosed
comorbidities such as depression, anxiety and unreported ADHD in young children with
ASD.
2.3 Design and Procedure
This was a single center, randomized, crossover pilot study design. In this pilot
study, it was proposed that participants receive a sequence of different treatment
approach, and each participant would be its own control.
However, due to COVID 19 pandemic and the closure of the MSC dental clinic,
the study was interrupted, and it was not possible to reach the washout period or complete
the crossover.
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After IRB approval, informed consent was obtained. Participants were randomly
assigned consecutively to start the study in the control or experimental group.
Due to limited time frame for the study, sessions were completed once a week for
eight weeks. All groups were equally treated except for the intervention (use of the App).


Intervention group (Task-oriented training): A Dental Visual Dental Support App
created by the principal investigator available at Google Play for Android Devices
was used for the intervention group as behavior management. The App consists of
an electronic visual support schedule with a total of 8 tasks that correspond to all
steps of a routine dental visit: Task 1- Sit down (patient seating in the dental chair
with or without parents), Task 2- Dental mirror (presenting the dental mirror to
patient and acceptance in patient’s mouth for visual examination of teeth), Task 3Open mouth (opening the mouth as requested -after mirror was used in previous
step- for additional examination of soft tissue including gingiva, tongue, and
palate), Task 4- Brush teeth (consists in completion of dental cleaning), Task 5Mr.Thirsty (presenting and acceptance of dental suction), Task 6- Mr. Shakey
(presenting and allowing the use of dental floss), Task 7- Little Brush (application
of fluoride varnish), Task 8- Treasure box (represents the end of the dental
appointment and patient can have a small prize from the clinic’s treasure box).



Control group: Tell-Show-Do, a basic non-pharmacological behavior
management technique was used for the control group. Tell- Show-Do consists of
verbal explanations of procedures in phrases appropriate to the developmental
level of the patient (tell); demonstrations for the patient of the visual, auditory,
olfactory, and tactile aspects of the procedure in a carefully defined,
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nonthreatening setting (show); and then, without deviating from the explanation
and demonstration, completion of the procedure (do).53 Tell-Show-Do will be
used throughout the appointment for the completion of the same 8 tasks as the
intervention group.
During the first visit for both groups, the distress level measurements was
recorded by 1) physiological markers: Heart Rate (HR) and a swab salivary cortisol test;
and 2) Venham’s Clinical Anxiety Scale.71 Distress was defined as the stress behavior
displayed by the child during the intervention. Heart Rate and Salivary cortisol are
biomarkers that have been previously used in studies as markers for stress assessment,
including in patients with ASD.72,73


Heart rate (HR): HR was measured at two moments during each dental visit with
a pulse oximeter for children. First, at the arrival of the patient, after seating in the
dental chair, before any other measurement is initiated, and at the end of all
procedures while patient is still seated in the dental chair.



Salivary cortisol test: It was planned that a total of 4 collections of saliva will be
completed for each participant. Two at the baseline visit (visit #1) and two at the
last visit (visit #8). Only the two collections during the first visit were completed.
Saliva collection was performed using a swab method (SalivaBio children swab)
obtained from Sialimetrics®. The salivary collections were done in intervals as
needed due to behavior until the lower third of the swab was saturated. The first
salivary collection during visit #1 was collected during the open mouth step of the
Visual Dental Support App. The second salivary collection of visit #1 was
completed after the patient completed the fluoride application. The salivary
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samples were frozen at -80 degrees within 6 hours of collection.
Material was sent to Sialimetrics SalivaLab for cortisol test on dry ice.


Venham’s clinical anxiety rating scale: Was completed by the pediatric dental
resident/faculty after the last task was completed during every visit.
Immediately after the last task was completed for every visit, the pediatric dental

resident or faculty administered the perception questionnaire to parents and coded the
patient’s behavior using the Frankl Behavioral Rating Scale.


Parental perception of behavior questionnaire: At the end of each visit, the parents
were asked to complete a short questionnaire about their perception of the
children’s behavior during the dental visit.
During the procedures, all data was recorded in a tool form (Appendix C) created

for the purpose of this investigation by the principal investigator.
Instrumentation:
The assessment of patient’s behavior was determined by the number of tasks
completed, the time needed to complete all tasks, parental perception questionnaire,
Venham’s clinical anxiety rating scale, and by Frankl Behavior Rating Scale.


Venham’s clinical anxiety rating scale:71,74 this tool was created by Venham, et al
to measure the anxiety level of children during the dental visit and it has been
validated. This scale has the following ratings: (1) relaxed; (2) uneasy; (3) tense;
(4) reluctant; (5) interference; and (6) out of contact or untreatable.



The Frankl Behavioral Rating Scale (4-point scale) is a reliable and frequently
used behavior rating systems in both clinical dentistry and research. This scale
separates observed behaviors into four categories ranging from definitely negative
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to definitely positive: (1) Definitely negative. Refusal of treatment, forceful
crying, fearfulness, or any other overt evidence of extreme negativism; (2)
Negative. Reluctance to accept treatment, uncooperative, some evidence of
negative attitude but not pronounced; (3) Positive. Acceptance to treatment,
cautious behavior at times, willingness to comply with the dentist, at times with
reservation, but patient follows the dentist’s directions cooperatively; (4)
Definitely positive. Good rapport with the dentist, interest in the dental
procedures, laughter, and enjoyment.


Parental perception of behavior questionnaire was designed by the principal
investigator to be used only for this study to obtain the parental perception of the
child’s behavior during the dental visit. The questionnaire consists of four
questions: Three yes or no questions and one Likert type question. (Appendix B)
The level of distress was determined by the heart rate and salivary cortisol levels.

In the original study design, the level of desensitization, defined as the diminished
emotional responsiveness to a negative, aversive or positive stimulus after repeated
exposure to it75 was to be determined by the number of visits needed to complete all the
tasks. Since the study was interrupted and multiple visits were not possible, this data
point was not included in the analysis.
2.4 Data Storage
All data collected was de-identified and entered in an Excel spread sheet. This
data was housed on a password protected computer. To stay in compliance with HIPAA
regulations and to maintain patient’s privacy, only research staff had access to the study
files. No identifying information was retained in the database.
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2.5 Statistical Analysis
Given that the study was interrupted, we were only able to enroll a total of 8
participants (4 assigned to the control group, and 4 assigned to the intervention group)
instead of the proposed 15. In addition, complete data was not collected for all participants
for the proposed 8 visits. Data for the proposed variables was collected during the first visit
from both the control and intervention groups. Unfortunately, due to the discontinuation of
the study, follow up data was only available for visits 2 and 3, but not for all participants.
For example, there was only 1 intervention group participant and 3 control group
participants with data for 3 visits. Given this, we did not have enough participants or follow
up data to compare. As such, the original data analysis plan had to be completely
restructured.
Descriptive statistics were calculated for all study variables. In addition, mean
values were calculated for all variables including heart rate, cortisol levels, number of tasks
completed, time to complete all tasks, and behavior and anxiety scales. Independent t-tests
based on data from visit 1 were conducted to compare the control and intervention groups
on all the proposed variables. Significance level was set at p=<0.05 for all comparisons.
Mean differences across 3 visits for the few available participants (1 participant from
intervention versus 3 in the control group) were plotted and examined for the following
variables: number of tasks completed, number of minutes to complete the tasks, and the
Frankl behavioral scale. For this design, the dependent variable was either number of tasks
completed, number of minutes to complete the tasks or score on the Frankl Behavioral
Scale; the within-subjects factor was "time" and the between-subjects factor was the
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condition (control or intervention group). General trendlines were examined, significance
could not be calculated.
Null hypothesis is that there was no difference in between the groups. ANOVA
models with the trough Heart Rate, Cortisol at baseline, and Time to complete all tasks (in
minutes), N. of tasks completed as dependent list and the intervention group as factors were
used.
2.6 Quality Control and Data Management
To maintain the quality of data collection, the principal investigator was the sole
person responsible for collecting and entering data. All the information collected on
paper was shredded and disposed according to the NSU IRB policy. Password protected,
de-identified datasets will be retained for 36 months following the completion of the
study, upon which they will be destroyed. Files from the computer will be deleted from
hard drive. The Protected Health Information will not be reused or disclosed to any other
person or entity, except as required by law, for authorized oversight of the research study,
or for other research for which the use or disclosure of protected health information
would be permitted.
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CHAPTER 3: RESULTS
The estimated sample size for this pilot study was 15 participants. Due to COVID
19 clinic closure, only 8 participants were enrolled in the study at the time of the closure.
Participants were aged 3 to 6 years old (mean age 4.1 years) and all were diagnosed with
ASD at the time of the study. Four participants completed routine dental care using the
App, and four using Tell Show Do. No significant difference was found in age, gender,
and ethnicity between intervention and control groups. The demographics of study
participants are shown in Table 1.
Table 1. Demographic characteristics of all study participants
Demographics

N

%

Male

8

100

Female
Ethnicity

0

0

1

12.5

Hispanic/Latino

3

37.5

African American

1

12.5

Other

3

37.5

Gender

White

All participants completed the first baseline visit. The baseline descriptive statistics of
participants are shown in Table 2.
Table 2. Baseline Descriptive Statistics at First Visit
Variable

N

Minimum

Maximum

Age
HR Initial

7
8

3
50

6
170

4.14
95.88

1.069
36.436

HR Final

7

94

113

101.57

6.321

Cortisol Initial
Cortisol Final

7
6

.096
.073

2.871
2.716

.60743
.65033

1.012235
1.021764

N. of tasks completed

8

2

8

6.75

2.188

Time to complete all
tasks (in minutes)

8

8.31

28.00

13.8025

6.11868
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Mean

Std. Deviation

Primary outcome
The primary and co-primary clinical outcome are reported in Table 3. With
response defined as number of tasks completed and time to complete all tasks in minutes
for participants using the App as compared to 50% (n=4) of participants using TSD. No
significant differences were observed between groups at second visit.
The dependent variables were "number of tasks completed" (as shown in Table 4
and figure 4) and the “time to complete all tasks” (as shown in Table 5 and figure 5), the
within-subjects factor was "time" and the between-subjects factor was the "conditions."
In one group, participants used a Tell Show Do during the dental visit (control group),
and in the other group, an Application on a tablet was used (treatment group).
Table 3. Change from baseline in mean of primary & co-primary outcome at second visit
App (n = 4)
mean (SD)
Heart Rate (bpm)

Measure

Baseline
Change at 2 Visits

Baseline
Change at 2 Visits

Baseline
Change at 2 Visits
Baseline
Change at 2 Visits

All (n=8)
mean (SD)
Initial
Final
Initial
Final
Initial
Final
Initial
Final

95.88 (36.4)
86 (25.2)
101.57 ()
99.25 (4.5)
134.67 (30.0)
111.5 (17.6)
93.60 (18.6)
94.0 (28.2)
Cortisol (mmHg)
.607 (1.01)
.950 (1.29)
.650 (1.02)
.874 (1.24)
.
.
.
.
Time to complete all tasks (in minutes)
13.80 (6.11)
11.38 (2.51)
11.04 (8.8)
4.8 (5.9)
N. of tasks completed
6.75 (2.18)
7.75 (0.50)
7.40 (1.34)
8.0 (.00)

TSD (n = 4)
mean (SD)

p-value*

105.75 (46.9)
104.6 (8.0)
134.67 (30.0)
93.33 (17.15)

.486
.301
.410
.975

.149 (0.32)
.202 (0.18)
.
.

.344
.510
-

16.22 (8.09)
15.19 (8.71)

.297
.245

5.75 (2.87)
7.0 (1.73)

.219
.495

*ANOVA models with the trough Heart Rate, Cortisol, at baseline, and Time to complete all tasks (in
minutes), N. of tasks completed as dependent list and the intervention group as factors were used.
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During this period, the dependent variable (number of tasks completed) was
measured three times: at the beginning of the study (baseline), at visit 1 (Time 1), visit 2
(Time 2) and Visit 3 (time 3).
Table 4. Number of Tasks Across Visits (Descriptive Statistics)
Group
Number of Tasks
Completed Visit 1

Number of Tasks
Completed Visit 2

Number of Tasks
Completed Visit 3

Mean

Std.
Deviation

N

control

6.00

3.464

3

intervention

8.00

.

1

Total

6.50

3.000

4

control

7.00

1.732

3

intervention

8.00

.

1

Total

7.25

1.500

4

control

7.00

1.732

3

intervention

8.00

.

1

Total

7.25

1.500

4

*Note: there was only 1 intervention group participant with data for 3 visits.

Figure 4. Estimated Marginal Means of Tasks completed
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Table 5. Number of Minutes to Complete Tasks (Descriptive Statistics)

Time to complete all tasks
(in minutes) Visit 1

Time to complete all tasks
(in minutes) Visit 2

Time to complete all tasks
(in minutes) Visit 3

Group

Mean

control

18.1267

8.74003

3

intervention

10.3600

.

1

Total

16.1850

8.12439

4

control

15.1933

8.71514

3

9.0000

.

1

Total

13.6450

7.76048

4

control

10.9400

5.03525

3

9.4500

.

1

10.5675

4.17822

4

intervention

intervention
Total

Std.
Deviation

N

*Note: there was only 1
intervention group
participant with data for 3
visits.

Figure 5. Estimated marginal means of minutes to complete all tasks.
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The mean Frankl Behavior score in the Intervention group (App) was 2.50 (SD=1.00) and
1.75 (SD=.500) in the control group (Tell Show Do). No significant difference was found
between the two groups (Independent Samples t-test: P = 0.953).

Figure 6. Clustered Bars of Frankl Behavior Scores by groups (Higher Scores=More
Positive Behavior). *Note: there was only 1 intervention group participant with data for 3
visits. Independent Samples t-test: p = 0.953.
The parental perception of overall child behavior during the dental visits is shown
in figure 7 with no statistical significance between groups. Independent Samples t-test: p
= 0.168.
The perception of the parents regarding the improvement in behavior towards the
end of the visit as shown in figure 8 was not statistically significant. Using a Fisher’s
Exact test, no difference was found (p = .214).
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There was no statistical difference of children cooperativeness during the dental
visit between groups as perceived by parents (p= .429).

Figure 7. Parents perception of the overall child behavior by groups. Pearson Chi-Square
(p= .102).

Figure 8. Parental perception of behavior improvement toward the end of the dental visit.
Using a Fisher’s Exact test, no difference was found (p = .214).
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Figure 9. Child cooperativeness as perceived by parents by groups. Using a Fisher’s
Exact test, no difference was found (p = .429).
Secondary outcomes
To assess the distress level experienced by children with ASD during the dental visit was
measured through the anxiety scale (Table 6) and physiological biomarkers: heart rate
and cortisol levels (Table 7, which also shows control versus intervention statistics in all
measures). Change from baseline in mean sitting heart rate and cortisol between baseline
and visit 2 is shown in Table 3.
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Table 6. Venham’s Clinical Anxiety Rating Scale Descriptive Statistics
Group
Anxiety Scale
visit 1
Anxiety Scale
visit 2
Anxiety Scale
visit 3

Mean

control
intervention
Total
control
intervention
Total
control
intervention
Total

5.00
1.00
4.00
4.00
1.00
3.25
3.00
1.00
2.50

Std.
Deviation
1.000
.
2.160
1.732
.
2.062
1.732
.
1.732

N
3
1
4
3
1
4
3
1
4

Venham’s Clinical Anxiety Rating Scale: Higher score=More anxiety

Figure 10. Estimated marginal means of anxiety scale
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Table 7. Control versus Intervention Group Statistics on all measures at baseline
Group
HR Initial 1

N

Mean

Std. Deviation

control

4

105.75

46.914

intervention

4

86.00

25.232

control

3

104.67

8.021

intervention

4

99.25

4.500

control

3

.15

.033

intervention

4

.95

1.297

control

2

.20

.018

intervention

4

.87

1.241

Number of Tasks

control

4

5.75

2.872

Completed visit 1

intervention

4

7.75

.500

Time to complete all tasks

control

4

16.2200

8.09116

(in minutes) Visit 1

intervention

4

11.3850

2.51081

Behavior Scale visit 1

control

4

1.75

.500

intervention

4

2.50

1.000

control

4

5.00

.816

intervention

4

3.75

1.893

HR Final 1

Cortisol Initial

Cortisol Final

Anxiety Scale visit 1

Independent Samples T-test Results: Control versus Intervention Group on all measures
*No statistically significant difference between the groups on any of these measures.
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CHAPTER 4: DISCUSSION
Demographic characteristics of this study’s participants showed a higher
prevalence of males, since all participants were males. It is thought that this was due to
the limited number of patients and represents a limitation for the study. But this
corresponds to the epidemiology of ASD with a current prevalence of 4 males to 1
female. 5
Patients with Autism Spectrum Disorder represent a challenge for dental
providers. The combination of their behavioral deficits and the nature of the therapeutic
intervention usually requires the administration of general anesthesia in about 40 percent
of cases.76
There are limited studies evaluating possible strategies for the management of
behavior for patients with ASD in the dental setting. This pilot study experimentally
compared the effectiveness of a visual support schedule App and Tell-show-do (TSD)
intervention for improving the behavior during a routine dental visit. The innovation of
this study involved using a digital tablet as a mediating tool between children with ASD
and the dentist to facilitate the dental visit. Due to the multiple advantages including ease
of use and the level of engagement for typically developing children and children with
ASD. The first null hypothesis was there is no improvement in behavior during a routine
dental visit for patients with ASD when using a visual support schedule App. Statistically
the null hypothesis was accepted. These results do not support the results by previous
studies.48,57 A previous study completed on 2019 using an iPad as a training program
during the dental visit showed an improvement in oral assessment because the children
became compliant and less anxious.48 Also, Zink et all reported an improvement in
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communication between the dentist and patients when using an App versus using Picture
Exchange Communication System (PECS), decreasing the number of appointments
required for preventive dental care and clinical examinations. 57
Even though there was no statistical significant difference between the groups,
clinically within the intervention group all participants were able to complete all tasks
given during the dental visit. Within the control group 50% (n=2) of participants could
complete all the tasks. A pilot study using visual support system in dental care for
patients with autism showed some promise in helping children with autism successfully
complete more tasks, progress at a quicker rate, and exhibit lower levels of behavioral
distress within a dental appointment, compared to a traditional tell-show-do approach. In
the current study the mean differences in time to complete all tasks between the groups
did not show a significant difference, that could also be due to limited number of
participants and premature interruption of the study.51
Dental anxiety has been considered one of the main challenges of behavior
management in pediatric dentistry and it should be addressed in order to provide high
quality dental treatment.63 It has been reported in the literature that one of the most
common comorbidities of individuals with autism is their high anxiety levels.9 The
present study did not show a significant difference in the level of distress. A difference
from the study completed by Ghadimi, et. all that reported a significant reduction on Selfreported dental anxiety when using visual distraction tool compared to conventional tellshow-do.63 Within the variables used to approximate to the distress levels of the
participants, biological markers as salivary cortisol levels were used, without a
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statistically significant result. Even though studies have proven that the measurement of
salivary cortisol may be a convenient method for the assessment of dental anxiety. 77
Some of the key strengths of this study include the practical application providing
alternative strategies to families and dental care providers to benefit children with oral
health care needs and behavior challenges. This project also included a multidisciplinary
approach for the management of patients with autism in the dental office consisting of
dentists and behavior analysts to provide individuals with patient focused, high quality
oral care. The study also has many limitations. Since it was a pilot study with a small
sample size, it was not possible to have enough statistical power to detect significant
differences between interventions. Discrepancy due to undiagnosed comorbidities such as
depression, anxiety and ADHD in young children with ASD not reported by parents
could also be a confounder in this study. Since the majority of our patients age ranged
from three to 6 years in age, it should be valuable to examine the use of the app among
children with ASD in different age groups in different clinical settings.
Even though numerous limitations exist our current investigation, this study can
be a contribution to the solution of unmet dental needs in children with ASD and can be
an addition to the literature in treating children with ASD.
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CHAPTER 5: CONCLUSION
Within the limitations of this study, it can be concluded that there was no
association between the use of the App and improvement in behavior during routine
dental visit for patients with ASD. The intervention did not improve the number of tasks
completed or decreased the time to complete all tasks. The same was evident when
comparing the groups regarding the behavior and anxiety scale.
The effectiveness of the App reducing anxiety and improving behavior in young
patients, to facilitate the dental intervention was not proven by this study. Biological
biomarkers were not statistically different between the groups.
The deficient data collected limits the possibility of drawing strong conclusions that the
App can facilitate a routine dental visit for patients with ASD.
It is suggested this research is allowed to continue in order to consider if the App
has more benefits for patients with ASD when visiting the dental office compared to the
existing standard of care for behavior management. We hope that successful routine
dental care can be made possible for these patients, using the methods outlined here,
without relying on advanced pharmacological techniques.

46

Appendix A- ASD Diagnostic Criteria DSM5
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Appendix B- Parental perception of behavior questionnaire
Parental perception of Children’s Behavior During Dental Visit.
Ana L. Gonzalez, DDS
Nova Southeastern University
Pediatric Dental Resident

1- Overall, how do you consider your child’s behavior during the dental visit today:
 Very bad
 Bad
 Good
 Very good
2- Was your child aggressive?
 Yes
 No
3- Do you consider there was an improvement of your child’s behavior towards the end of
the procedure?
 Yes
 No
4-

Was your child cooperative overall for dental procedures today?
 Yes
 No
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Appendix C- Data Collection Form
Patient Code:
Gender:

Age:
Race/Ethnicity:



Male



Female








Date:

Visit 1
Heart Rate: Initial:

White
Hispanic/Latino
African American
Asian
Unknown
Other

Final:

Salivary Cortisol level:

Number of Tasks completed:

Time to complete all tasks:

Visit 2

Date:

Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:

Visit 3

Date:

Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:

Visit 4

Date:

Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:
Washout Period and Crossover
Date:

Visit 5
Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:

Visit 6

Date:

Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:

Visit 7

Date:

Heart Rate: Initial:

Final:

Number of Tasks completed:

Time to complete all tasks:

Visit 8

Date:

Heart Rate: Initial:
Number of Tasks completed:

Final:
Time to complete all tasks:

50

Initial:

Final:

Appendix D- Raw Data

Code

1

Group (1=
Gender Hispanic
Total
HR
Intervention, (0=M Ethnicity number Initial
0=Control)
1=F)
(0=no
of visits
1
1=yes)
0
0
0
4
170

2
3
4
5
6
7
8

Code

1
2
3
4
5

1
0
1
0
1
0
1

0
0
0
0
0
0
0

0
1
1
0
0
0
1

HR
HR
HR
HR
Initial Final Initial Final
3
3
4
4
98

99
102

157

100
95
98

114

106

147

92

1
4
3
3
2
1
1

HR
Initial
2

HR
Final
2

Not taken
due to
behavior
99
97
94
104
105
113
99

136

109

104
99
164
124

96
74
75
114

Cortisol
Initial

Cortisol
Final

qns- quantity
not sufficient
0.245
0.16
2.871
0.113

not taken

135
6
7
8

99
111
88
67
50
75
107

HR Final 1

0.591
0.176
0.096
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0.209
0.189
2.716
Not
sufficient
sample
0.5
0.215
0.073

Number of Number of
Tasks
Tasks
Completed Completed
visit 1
visit 2
2
5
7
8
8
8

8
5
8

8
8
8

8

Cod
e

Number
of Tasks
Complete
d3

Number
of Tasks
Complete
d visit 4

1
2
3
4
5
6
7
8

5

6

8
8
8

8

Code

Time to
complet
e all
tasks (in
minutes
) Visit 1
15
13.46
11.38
10.36
28
13.41
10.5
8.31

Time to
complet
e all
tasks (in
minutes
) Visit 2
20.2

Time to
complet
e all
tasks (in
minutes
) Visit 3
12.15

Time to
complet
e all
tasks (in
minutes
) Visit 4
14.39

5.13
9
20.25
13.03

5.41
9.45
15.26

5.32

Behavior Behavior Anxiety
Scale
Scale
Scale
visit 3
visit 4
visit 1

Anxiety
Scale
visit 2

Anxiety
Scale
visit 3

Anxiety
Scale
visit 4

1
2

1

2

6
5

5

4

5

3

3

4

4

2

1

1

4

2

1

1

1

5
6
7
8

2

5
5
5
4

5
2

4
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Behavi
or Scale
visit 1

Behavi
or Scale
visit 2

1
2
2
4
2
2
2
2

1
3
4
2
3

Overall, Overall,
how do
how do
you
you
consider consider
your
your
child’s
child’s
behavior behavior
during
during
the
the
dental
dental
visit
visit
today:
today:
(1)
(2)
very bad very bad
very
good
good
very
good
very
very
good
good
good
good
good
good
bad
very
good

Code

1
2
3

Overall,
how do
you
consider
your
child’s
behavior
during
the
dental
visit
today:(4)
bad

Was your
child
aggressive?
(1)

Was your
child
aggressive?
(2)

Was your
child
aggressive?
(3)

Was your
child
aggressive?
(4)

no
no
no

no

no

no

no

no

no

no
no
no
no
no

no
no
no

no
no

very
good

4
5
6
7
8
Code

1
2
3
4
5
6
7
8

Do you
consider
there was
an
improveme
nt of your
child’s
behavior
towards the
end of the
procedure?
(3)
no

Do you
consider
there was
an
improveme
nt of your
child’s
behavior
towards the
end of the
procedure?
(4)
yes

yes
yes
yes

yes

Do you
consider
there was
an
improveme
nt of your
child’s
behavior
towards the
end of the
procedure?
(1)
no
yes
yes
yes
no
yes
yes
yes

Was your
child
cooperativ
e overall
for dental
procedure
s today?
(1)

Was your
child
cooperativ
e overall
for dental
procedure
s today?
(2)

Was your
child
cooperativ
e overall
for dental
procedure
s today?
(3)

Was your
child
cooperativ
e overall
for dental
procedures
today? (4)

no
yes
yes
yes
no
yes
yes
yes

no

no

no

yes
yes
yes
yes

yes
yes
yes

yes
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